Want to see JP:3386 full AI Analyst Report?
Cosmo Bio Co., Ltd. (3386) Financial Statements
Cosmo Bio Co., Ltd. Financial Overview
Cosmo Bio Co., Ltd.'s market cap is currently $7.16B. The company's EPS TTM is $64.15; its P/E ratio is 19.27; and it has a dividend yield of 4.05%. Cosmo Bio Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 10.77B | $ 10.04B | $ 9.34B | $ 9.55B | $ 9.23B |
| Gross Profit | $ 3.70B | $ 3.33B | $ 3.25B | $ 3.44B | $ 3.66B |
| Operating Income | $ 342.00M | $ 318.00M | $ 519.00M | $ 816.00M | $ 1.05B |
| EBITDA | $ 509.00M | $ 455.00M | $ 801.00M | $ 931.00M | $ 1.26B |
| Net Income | $ 336.00M | $ 262.00M | $ 442.00M | $ 517.00M | $ 737.00M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 2.95B | $ 2.69B | $ 3.02B | $ 3.04B | $ 3.56B |
| Total Assets | $ 12.66B | $ 11.72B | $ 10.87B | $ 10.31B | $ 10.07B |
| Total Debt | $ 20.00M | $ 22.00M | $ 24.00M | $ 27.00M | $ 28.00M |
| Net Debt | $ -2.73B | $ -2.37B | $ -2.80B | $ -3.01B | $ -3.23B |
| Total Liabilities | $ 2.70B | $ 2.17B | $ 1.84B | $ 1.69B | $ 1.75B |
| Stockholders' Equity | $ 9.37B | $ 8.97B | $ 8.45B | $ 8.05B | $ 7.79B |
| Cash Flow | |||||
| Free Cash Flow | $ 366.00M | $ 25.00M | $ 636.00M | $ 180.00M | $ 507.00M |
| Operating Cash Flow | $ 595.00M | $ 241.00M | $ 736.00M | $ 284.00M | $ 648.00M |
| Investing Cash Flow | $ 43.00M | $ -217.00M | $ -758.00M | $ -291.00M | $ -145.00M |
| Financing Cash Flow | $ -283.00M | $ -479.00M | $ -201.00M | $ -236.00M | $ -420.00M |
Currency in JPY